Patient reported outcome and experience measures among patients with central venous access devices: a systematic review
Authors:
- Emily N. LarsenELEmily N. Larsen
- Claire M. RickardCRClaire M. Rickard
- Nicole MarshNMNicole Marsh
- Mary FennMFMary Fenn
- Rebecca S. PatersonRPRebecca S. Paterson
- Amanda J. UllmanAUAmanda J. Ullman
- Raymond J. ChanRCRaymond J. Chan
- Vineet ChopraVCVineet Chopra
- Doreen TapsallDTDoreen Tapsall
- Amanda CorleyACAmanda Corley
- Nicole GavinNGNicole Gavin
- Brighid ScanlonBSBrighid Scanlon
- 5 November 2024
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (12) , 1-12
Abstract
Purpose Patients receiving treatment for solid tumours and haematological malignancies, among other acute and chronic health conditions, are highly dependent upon central venous access devices (CVADs) for administering chemotherapy and other complex therapies; thus, CVADs can meaningfully impact their health outcomes and experiences. This systematic review aimed to identify and critique patient-reported outcome measure (PROM) and patient-reported experience measure (PREM) instruments related to CVADs. Methods A systematic review was undertaken, commencing with an electronic search of health databases (April 2022). Studies were eligible if they used a self-reporting instrument (questionnaire) to quantitatively measure patient-reported outcomes and experiences related to CVADs (English only). Using a piloted data-extraction tool, two authors independently identified studies for full review, data extraction, and quality assessment. Data were synthesised narratively. Results The search yielded 875 titles, of which 41 met the inclusion and no exclusion criteria. Of these, 31 reported results of purpose-built questionnaires; a further six reported results of generic measures used for CVADs; four included both purpose-built and generic measures. Overall study quality was low; only two studies evaluated both content validity and internal consistency. In total, 155 unique PROM items (across 27 studies) were extracted which encompassed five domains (e.g., ‘Instrumental activities of daily living’; ‘Pain and discomfort’). Similarly, 184 unique PREMs (from 31 studies) included 13 domains (e.g., ‘Shared decision-making’; ‘Education’). Conclusion Increasingly, research and quality improvement studies about CVADs are incorporating PROM and PREM. These measures are largely purpose-built, however, and their validity and reliability have not been sufficiently established for use. Review registration Prospectively submitted to the International prospective register of systematic reviews (PROSPERO) 05 July 2020.Keywords
Funding Information
- Griffith University Health Group (2019, 2019, 2019, 2019, 2019, 2019, 2019)
This publication has 66 references indexed in Scilit:
- Adult oncology patients’ experiences of living with a central venous catheter: a systematic review and meta-synthesisSupportive Care in Cancer, 2022
- Comparative Complication Rates of 854 Central Venous Access Devices for Home Parenteral Nutrition in Cancer Patients: A Prospective Study of Over 169,000 Catheter‐DaysJournal of Parenteral and Enteral Nutrition, 2020
- Patient experiences with peripherally inserted venous catheters— A cross‐sectional, multicentre study in NorwayNursing Open, 2020
- Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communicationSupportive Care in Cancer, 2017
- Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placementSupportive Care in Cancer, 2016
- Morbidity of Chemotherapy Administration and Satisfaction in Breast Cancer Patients: A Comparative Study of Totally Implantable Venous Access Device (TIVAD) Versus Peripheral Venous Access UsageWorld Journal of Surgery, 2013
- Percutaneous image-guided implantation of totally implantable venous access ports in the forearm or the chest? A patients’ point of viewSupportive Care in Cancer, 2012
- Systematic review: malfunction of totally implantable venous access devices in cancer patientsSupportive Care in Cancer, 2011
- No impact of central venous insertion site on oncology patients’ quality of life and psychological distress. A randomized three-arm trialSupportive Care in Cancer, 2010
- Patients’ perceptions of having a central venous catheter or a totally implantable subcutaneous port system–results from a randomised study in acute leukaemiaSupportive Care in Cancer, 2008